Oncology

Latest News

David Nguyen, MD | Image Credit: Tufts Medicine
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD

July 23rd 2025

David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies

Emerging therapies, including immune checkpoint inhibitors and antibody-drug conjugates, could significantly impact SCLC treatment, authors of a recent review concluded. | Image credit: Vitalii Vodolazskyi - stock.adobe.com
Is a New Era of SCLC, LCNEC Treatments on the Horizon?

July 23rd 2025

Christine Pfaff, MBA, RPh | Image: LinkedIn
COA Welcomes Christine Pfaff, MBA, RPh, to Leadership Team

July 22nd 2025

AJMC Q&A with Robert Kratzke | Background image credit: ipopba - stock.adobe.com
Making Reflexive Testing the Standard of Care in Lung Cancer: Robert Kratzke, MD

July 22nd 2025

Cancer diagnosis financial strain | Image Credit: Maggie-sort.chatgpt.com
Cancer Diagnoses Bring Major Financial Burden for Privately Insured Adults

July 21st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
July 23rd 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 23rd 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Applying Personalized Medicine to Impact Outcomes in Different Cancer Types
October 29th 2015

Applying Personalized Medicine to Impact Outcomes in Different Cancer Types

Coverage Decisions for Personalized Medicine
October 29th 2015

Coverage Decisions for Personalized Medicine

Advantages of a Personalized Approach to Cancer Care
October 29th 2015

Advantages of a Personalized Approach to Cancer Care

Evolution of Personalized Medicine
October 29th 2015

Evolution of Personalized Medicine

Site Logo
October 29th 2015

Olaparib Effective in mCRPC

Surabhi Dangi-Garimella, PhD
Olaparib, a PARP inhibitor approved for treating BRCA1/2-mutated ovarian cancer, has been found effective in treating men with metastatic, castrate-resistant prostate cancer.
Site Logo
October 29th 2015

Ipilimumab Approved in Adjuvant Setting to Prevent Relapse in Advanced Melanoma

Surabhi Dangi-Garimella, PhD
The drug significantly delayed recurrence of the cancer in patients treated post surgery.
Site Logo
October 28th 2015

Payment Reform Pilot Updates at the COA Payer Summit

Surabhi Dangi-Garimella, PhD
Payer—provider teams presented updates on their cost-saving pilot projects and looked to the future of these models in oncology care.
Site Logo
October 28th 2015

Cost Questions Will Follow the Approval of Amgen's Oncolytic Viral Treatment, Imlygic

Surabhi Dangi-Garimella, PhD
The company says the treatment will cost an average of $65,000.
Site Logo
October 27th 2015

ASCO Demands Revamp of Site Neutrality Policy in Oncology

Surabhi Dangi-Garimella, PhD
The ASCO statement emphasizes patient-centered reform that weighs-in the value of the services rendered.
Site Logo
October 27th 2015

Confusion Reigns in Wake of Study Linking Processed Meat to Cancer

Mary K. Caffrey
A study shows too much conflicting dietary advice causes some people to tune it all out. Nuances in the report from WHO are lost on most consumers.
Site Logo
October 27th 2015

Amgen's T-Vec to Receive FDA Decision Today

AJMC Staff
The vaccine, approved in Europe last week, is now awaiting approval in the United States.
Site Logo
October 26th 2015

Beyond the Disease: the Economic Hardships of Cancer

Surabhi Dangi-Garimella, PhD
A study published in the journal Cancer presents the financial impact of cancer on a survivor and his family.
This Week in Managed Care: October 24, 2015
October 24th 2015

This Week in Managed Care: October 24, 2015

This week in managed care, documents show Horizon Blue Cross Blue Shield of NJ rolled out OMNIA prior to receiving regulatory approval, 2 Harvard professors argue the merit of the annual physical, and experts weigh in on the successes and flaws of Medicare Part D.
Site Logo
October 23rd 2015

Amgen's First-in-Class Viral Drug, T-Vec, Could Soon Be Approved by EMA

AJMC Staff
The drug is awaiting an FDA verdict next week.
Site Logo
October 23rd 2015

5 Things to Know About 340B

Surabhi Dangi-Garimella, PhD
As the date for the comment period on the proposed guidance by HHS on 340B drug pricing draws near, read about the program and its impact on healthcare overall.
Site Logo
October 23rd 2015

Harvard Researchers Identify Racial Disparity in Care of Cancer Patients on Medicare

Surabhi Dangi-Garimella, PhD
Published in JAMA Oncology, the study found a significant difference in quality and access to care for black patients diagnosed with localized prostate cancer.
Site Logo
October 22nd 2015

Urology Cancer Patients Faced Neglect at Arizona VA Hospital

Surabhi Dangi-Garimella, PhD
Patients with cancer in the urology clinic at a VA hospital in Arizona may have suffered adverse outcomes due to clinical disconnect and staff shortage.
Site Logo
October 22nd 2015

Onivyde Approved for Advanced Pancreatic Cancer

AJMC Staff
Patients with metastatic pancreatic cancer who have progressed on gemcitabine now have the option of Onivyde combined with leucovorin/fluorouracil.
Site Logo
October 22nd 2015

ERLS Improves Functional Status Post Oncologic Liver Surgery

Surabhi Dangi-Garimella, PhD
A study published in the Journal of the American College of Surgeons found that including patients in the Enhanced Recovery program has a dramatic impact on their recovery post surgery.
Site Logo
October 21st 2015

LIVESTRONG Fertility Training Helping Empowers Healthcare Professionals With Tools for Cancer Care

Earlier this year, the LIVESTRONG Foundation launched a project to fill a critical gap in cancer care: training healthcare professionals to offer fertility services for adolescent and young adult patients. A new commentary in Evidence-Based Oncology discusses the barriers to fertility training and why is essential to overcome them.
Site Logo
October 21st 2015

The Benefit of Marrying PROs With Coordinated Care in Advanced Cancer Patients

Surabhi Dangi-Garimella, PhD
A presentation at the annual meeting of the American Society for Radiation Oncology underscored the importance of patient-centered care and the benefit of incorporating the patient voice in advanced oncology care.
Dr Laura Long Outlines the Difficulty of Measuring Quality of Life
October 21st 2015

Dr Laura Long Outlines the Difficulty of Measuring Quality of Life

Measuring quality of life in oncology care is difficult for a number of reasons, but Laura Long, MD, MPH, president at TheLongView, PC, expects that to change in the future.
Site Logo
October 21st 2015

Do Surrogate Endpoints Fail the Litmus Test?

Surabhi Dangi-Garimella, PhD
A letter published in JAMA Internal Medicine questions the FDA's acceptance of surrogate endpoints for what the authors describe as "costly, toxic drugs that do not improve overall survival."
Site Logo
October 20th 2015

American Cancer Society Now Recommends Delayed and Less Frequent Screening Mammograms

Surabhi Dangi-Garimella, PhD
A new evidence-based guidance update provided by the American Cancer Society, published yesterday in JAMA Internal Medicine, recommends a delay in initiating screening mammograms in women with an average risk of developing the disease.
Site Logo
October 19th 2015

Lower-Income Cancer Patients Less Likely to Participate in Clinical Trials

Jackie Syrop
A recent study finds that newly diagnosed cancer patients with incomes below $50,000 are less likely to participate in clinical trials than patients with higher incomes, providing more evidence that income disparities in trial participation remains a serious problem.
Site Logo
October 19th 2015

Ensuring Education for Stakeholders of Personalized Medicine

Surabhi Dangi-Garimella, PhD
A panel discussion at the PMC/BIO Solutions Summit in Washington, DC, saw an exchange on widespread and appropriate education of personalized medicine among payers, providers, patients, and families.
Dr Veena Shankaran Examines Financial Burdens Facing Cancer Patients
October 18th 2015

Dr Veena Shankaran Examines Financial Burdens Facing Cancer Patients

There are a number of financial hardships patients with cancer can face, even if they are insured, such as loss of employment, depletion of retirement accounts, and bankruptcy, said Veena Shankaran, MD, MS.
This Week in Managed Care: October 17, 2015
October 17th 2015

This Week in Managed Care: October 17, 2015

Top managed care stories this week include comparing US healthcare spending and outcomes to other wealthy nations, identifying how many Americans are affected by Medicaid expansion coverage gaps, and a look at adolescents and young patients with cancer.
Site Logo
October 16th 2015

NCCN Unveils Value Tool for CML and MM

AJMC Staff
NCCN Evidence Blocks add affordability to Guidelines recommendations on safety, efficacy, quality, and consistency of regimens.
Site Logo
October 16th 2015

Antibiotic Resistance Can Negate the Value of Surgery and Cancer Immunotherapy

Surabhi Dangi-Garimella, PhD
The results of a study published in The Lancet Infectious Diseases necessitate a wake-up call for stakeholders to develop a new approach that can overcome the rapidly-growing threat of antibiotic resistance.
<1
...
119120121122123124125126127
...
186>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo